Together with adopting a healthy lifestyle, Medicines are important pillar in
keeping healthy or getting our health back if we may have been ill. However, we
often know very little about the medicines we use. This section is a guide to the
numerous medicines that are registered in Kenya.
We appreciate your feedback! [Last updated Dec:2011]
Displaying 4191-4200 of 12466 results.
Product Name | Dosage Form | Active Ingredients | Manufacturer Name | Class | |
---|---|---|---|---|---|
TARCEVA TABLETS 25MG | TABLETS | Erlotinib (as Hydrochloride) 25 mg | F. HOFFMANN- LA ROCHE | ANTINEOPLASTICS & IMMUNOSUPPRESSIVE DRUGS | Report Effects |
HERCEPTIN 440MG TABLETS | TABLETS | TRASTUZUMAB 440MG | F. HOFFMANN- LA ROCHE LTD; SWITZERLAND | ANTINEOPLASTICS & IMMUNOSUPPRESSIVE DRUGS | Report Effects |
BONDRONAT 6MG/6ML I.V. INFUSION | INFUSION | IBANDRONIC ACID 6MG | F. HOFFMANN- LAROCHE LTD | ANTINEOPLASTICS & IMMUNOSUPPRESSIVE DRUGS | Report Effects |
AVASTIN INJECTION 100MG/4ML | INJECTION | Bevacizumab 100 mg | F. HOFFMANN-LA ROCHE | ANTINEOPLASTICS & IMMUNOSUPPRESSIVE DRUGS | Report Effects |
NEULASTIM 6MG/0.6ML INJECTION | INJECTION | PEGFILGRASTIM 6 MG | F. HOFFMANN-LA ROCHE | ANTINEOPLASTICS & IMMUNOSUPPRESSIVE DRUGS | Report Effects |
VALCYTE 450MG TABLETS | TABLETS | VALGANCICLOVIR HCL EQUIVALENT TO VALGANCICLOVIR 450 MG | F. HOFFMANN-LA ROCHE | ANTI-FUNGALS | Report Effects |
TAMIFLU 75MG CAPSULES | CAPSULES | Oseltamivir 75 mg | F. HOFFMANN-LA ROCHE LTD; SWITZERLAND | RESPIRATORY TRACT DRUGS | Report Effects |
MABTHERA 100 MG/10 ML INJECTION | INJECTION | Active Ingredient per ml: Rituximab 10 mg | F. HOFMANN-LA ROCHE LTD | ANALGESICS ANTIPYRETICS, NSAIDs | Report Effects |
MABTHERA 500 MG/50 ML INJECTION | INJECTION | Active Ingredient per ml: Rituximab 10 mg | F. HOFMANN-LA ROCHE LTD | ANALGESICS ANTIPYRETICS, NSAIDs | Report Effects |
SANGOBION | CAPSULE | VITAMIN B5 7.5MG, MANGENESE SO4 155MG, B2O 1MG, FOLIC ACID 200 MG, COOPER SO4 15MG. SOBITAL 50MG, IRON GLUCONATE 250MG. | F. MERCK DERMASTADT | VITAMIN & MINERALS | Report Effects |